El-ASSAL, MONA IBRAHIM, and DALIA SAMUEL. “OPTIMIZATION OF RIVASTIGMINE CHITOSAN NANOPARTICLES FOR NEURODEGENERATIVE ALZHEIMER; IN VITRO AND EX VIVO CHARACTERIZATIONS”. International Journal of Pharmacy and Pharmaceutical Sciences 14, no. 1 (January 1, 2022): 17–27. Accessed May 6, 2024. https://journals.innovareacademics.in/index.php/ijpps/article/view/43145.